Formulary Monographs [OCTREOTIDE, 9292]
|
|
OCTREOTIDE
|
|
|
|
|
|
OTHER THERAPEUTIC AGENTS
|
|
|
Symptomatic management of neuroendocrine tumours.
|
|
|
Anorexia, nausea, vomiting, diarrhoea and steatorrhoea, abdominal discomfort, and flatulence.
|
|
|
Initially 50 micrograms 1–2 times a day , adjusted according to resp onse; increased to 200 micrograms 3 times a day.
|
|
|
|
|
|
|
|
|
|
|
|
|